Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
Researchers conducted a population-based cohort study involving patients with T2D aged 18 years and older initiating treatment with SGLT-2i or metformin.
Heart Failure
ACC Issues Expert Guidance for Cardiovascular Sequelae After SARS-CoV-2 Infection
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
Metformin and Improved Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.
Recommendations Updated for Management of Heart Failure
Sodium-glucose cotransporter-2 inhibitors recommended for HF with reduced, mildly reduced ejection fraction.
Trends in Health-Related Quality of Life Among Patients With Advanced Heart Failure
Researchers compared heart transplant candidates and patients considering mechanical circulatory support to determine differences in health-related quality of life.
Jardiance Approved for Heart Failure Independent of LVEF
The approval was based on data from the phase 3 EMPEROR-Preserved trial.
Aspirin Use Tied to Incident Heart Failure in At-Risk Adults
Aspirin use was associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
Heart Attack + COVID-19 Significantly Ups In-Hospital Mortality
Findings for both out-of-hospital and in-hospital ST-segment elevation myocardial infarction.
World Heart Day: 5 Ways Your Patients Can Reduce Cardiovascular Disease Risk
It has been estimated that cardiovascular disease (CVD) claims 18.6 million lives per year. As World Heart Day seeks to raise awareness on CVD prevention and management, what are some ways your patients can reduce their risk?
Echocardiographic Phenotypes Predict Long-Term Outcomes in Asymptomatic HF
Echocardiographic phenotypes significantly improved the prognostic performance on top of the ARIC HF risk score, and discriminative values were “consistently observed on top of traditionally defined cardiac structure or function abnormalities.”
- Loading...
Loading...
Next post in Heart Failure Information Center
Loading... 
Loading...